Navigation Links
Vasomedical to Report Third Quarter 2013 Results on November 14, 2013
Date:11/5/2013

WESTBURY, N.Y., Nov. 5, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months ended September 30, 2013 on Thursday, November 14, 2013.

The Company will host a conference call on Thursday, November 14th at 1:00 p.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical, and Michael Beecher, Chief Financial Officer of Vasomedical. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669, internationally. All dial-in participants must use the following code to access the call: 94523097. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical's website, www.vasomedical.com, and www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available approximately two hours after completion of the live conference call at www.vasomedical.com or www.kcsa.com. To access the dial-in replay of the call, which will be available until December 16, 2013, please dial 1-855-859-2056 or 1-404-537-3406. All dial-in participants must use the following code to access the call: 94523097.

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sal
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vasomedical Announces Financial Results for the Second Quarter of 2013
2. Vasomedical to Report Second Quarter 2013 Results on August 13, 2013
3. Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
4. Vasomedical Announces Financial Results for the First Quarter of 2013
5. Vasomedical to Report First Quarter 2013 Results on May 15, 2013
6. Randy Hill Appointed to Vasomedical Board of Directors
7. Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
8. Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
9. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
10. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014 Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in the 2014 Morgan Stanley Global Healthcare Conference ... Burbach , President and Chief Executive Officer, will provide ... Eastern Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3US CNS Disorders Drug Pipeline Insight 2014 2
... The annual meeting of the Chinese food industry is ... June, heavily focusing on the growing health market in China, and ... and discuss business developments in the country and beyond. ... and China continues to enjoy a global reputation for being a ...
... Amgen (Nasdaq: AMGN ) today announced the ... compared XGEVA ™ (denosumab) to Zometa ® (zoledronic ... 1,901 men with prostate cancer and bone metastases. The study, ... secondary endpoints and demonstrated XGEVA,s superiority compared to Zometa in ...
Cached Medicine Technology:Health on the Agenda at Food ingredients Asia-China Trade Show 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
(Date:8/31/2014)... Sunday 31 August 2014: Mortality and morbidity of ... despite good use of oral anticoagulants, according to the ... Pilot Registry. The findings were presented for the first ... Professor Gregory Lip (Birmingham, UK). , Professor Lip said: ... on management practices of European cardiologists conducted since the ...
(Date:8/30/2014)... Spain Sunday 31 August 2014: A new ... and powered by heart motion was presented at ... Switzerland. The prototype device does not require battery ... the Cardiovascular Engineering Group at ARTORG, University of ... in today,s medical implants. Once they reach a ...
(Date:8/30/2014)... In a world where a typical response to conflict is ... a game app to teach another way. Launched in ... is a colorful way to encourage moral values playfully. ... double-duty by teaching players new ways to find happiness and ... for consistently taking the high road, the Ultimate Karma game ...
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis Automotive joined ... awareness for ALS by participating in the popular ALS ... Vice President Jimmy Ellis all participated in the challenge ... on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . , In ... staff also took the opportunity to challenge various businesses ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 The ... modeling the body that will reveal to users some shocking ... lead to great results in modeling looks, as well as ... the new method says that there is one unique trick ... new method indicates that despite what many people might think, ...
Breaking Medicine News(10 mins):Health News:AF mortality and morbidity high at 1 year despite good anticoagulant use 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2
... AND EFFECTIVE FOR COPD , Previous research has ... risk for adverse events or respiratory-related death in patients ... (COPD); however, a recent article shows this may not ... Spain, Argentina, and Uruguay reviewed the results of 27 ...
... research suggests that high-risk women with breast cancer who do ... for developing a second breast cancer than previously thought. ... sentinel node biopsy be considered at the time of prophylactic ... findings? , The increased risk of developing breast cancer ...
... could help bridge this knowledge gap, experts say , , ... of babies have a surprisingly low knowledge of child ... know or how they should act, a new study ... parents don,t know that 1-year-olds can,t tell the difference ...
... hospitalizing young children for influenza creates a significant economic ... preventive flu shots for children and the people with ... by Cincinnati Childrens Hospital Medical Center and presented May ... Honolulu, Hawaii. , After analyzing data in three U.S. ...
... surprisingly low-level knowledge of typical infant development and ... emotional growth, according research from the University of ... false parenting assumptions can not only impair parent-child ... stimulation, will be presented Sunday, May 4, at ...
... designed to block the neurotransmitter acetylcholine including common ... are more likely to be dependent in one or ... according to new findings from researchers at Wake Forest ... which involve a class of drugs known as anticholinergic ...
Cached Medicine News:Health News:News briefs: May issue of the journal Chest 2Health News:Second breast cancer may be greater than thought for high-risk women without BRCA mutations 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3Health News:Young children hospitalized for flu associated with higher costs and higher risk illness 2Health News:Nearly one-third of US parents don't know what to expect of infants 2Health News:Commonly used medications associated with impaired physical function in older adults 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: